Evusheld no longer a tool for people with cancer

The FDA recently announced Evusheld is no longer authorized for emergency use in the U.S. as it is no longer effective against current COVID-19 variants. Evusheld, an antibody therapy, previously was an essential tool used for pre-exposure protection against COVID-19 infection, especially for people with compromised immune systems including people with cancer. 

Antiviral medications continue to remain effective against current circulating COVID-19 variants.

People who are moderately to severely immunocompromised, those who might have an inadequate immune response to COVID-19 vaccination, and those who cannot receive COVID-19 vaccines, are urged to exercise caution and follow additional preventive measures.

Learn more.

If you have a weakened immune system, or live with someone who does, the CDC recommends the following:

Leave a Reply

Your email address will not be published. Required fields are marked *